Diferencia entre revisiones de «Template:Uncomplicated Diverticulitis Antibiotics»
(Metronidazole from q6h to q8h dosing) |
Sin resumen de edición |
||
| Línea 1: | Línea 1: | ||
'''Options:''' | '''Options:''' | ||
*[[Metronidazole]] 500mg PO Q8hrs AND [[Ciprofloxacin]] 500mg PO BID x10-14d | *[[Metronidazole]] 500mg PO Q8hrs AND [[Ciprofloxacin]] 500mg PO BID x10-14d | ||
*[[Amoxicillin/Clavulanate]] 875/125 PO | *[[Amoxicillin/Clavulanate]] 875/125 PO Q8hrs x10-14d (or [[Augmentin]] XR 2 tablets BID [each tablet 1gm [[amoxicillin]] 62.5mg clavulanate])<ref>Balasubramanian I et al. Out-Patient Management of Mild or Uncomplicated Diverticulitis: A Systematic Review. Dig Surg. 2017;34(2):151-160.</ref> | ||
*[[Trimethoprim/Sulfamethoxazole]], one double-strength tablet bid, and [[Metronidazole]] 500 mg Q8h | *[[Trimethoprim/Sulfamethoxazole]], one double-strength tablet bid, and [[Metronidazole]] 500 mg Q8h | ||
Revisión del 19:07 12 mar 2020
Options:
- Metronidazole 500mg PO Q8hrs AND Ciprofloxacin 500mg PO BID x10-14d
- Amoxicillin/Clavulanate 875/125 PO Q8hrs x10-14d (or Augmentin XR 2 tablets BID [each tablet 1gm amoxicillin 62.5mg clavulanate])[1]
- Trimethoprim/Sulfamethoxazole, one double-strength tablet bid, and Metronidazole 500 mg Q8h
- ↑ Balasubramanian I et al. Out-Patient Management of Mild or Uncomplicated Diverticulitis: A Systematic Review. Dig Surg. 2017;34(2):151-160.